Wenjing Xu

机构：Modern Electron (United States), Zhejiang Modern Architectural Design & Research Institute, Hainan Medical University · ORCID：0000-0001-9109-0133

发表论文 119 篇 · 总被引 2617 次 · h-index 28

代表论文

• Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1/IGFBP2 axis to suppress the development of prostate cancer (2024 · Journal of Experimental & Clinical Cancer Research · 被引 39)
• Rising above: exploring the therapeutic potential of natural product-based compounds in human cancer treatment (2024 · Traditional Medicine Research · 被引 24)
• Global Burden of Major Chronic Liver Diseases in 2021 (2025 · Liver International · 被引 19)
• A computer-aided, heterodimer-based “triadic” carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency (2024 · Journal of Colloid and Interface Science · 被引 14)
• Icariin‑curcumol promotes ferroptosis in prostate cancer cells through Nrf2/HO‑1 signaling (2024 · Experimental and Therapeutic Medicine · 被引 11)
• Triple‑negative breast cancer cell‑derived piR‑31115 promotes the proliferation and migration of endothelial cells via METTL3‑mediated m6A modification of YAP1 (2025 · Oncology Reports · 被引 7)